Keyword: Catalent

Are there certain types of clinical sponsors and studies that are at greater risk of experiencing supply challenges?

Direct-to-patient (DTP) distribution of clinical supplies provides trial sponsors with the opportunity to support improved recruitment and retention rates for their studies by removing or reducing the travel and time commitments that can otherwise inhibit patients’ willingness and ability to participate.

In this webinar, AstraZeneca and Catalent Biologics experts will share a case study on a 30-day commercial launch plan for a product into new markets and why this approach was important for patients.

What are the critical factors for OTC products to achieve consumer engagement and retail success?

Register for this webinar to learn about the tools and technologies for creating dosage forms such as orally disintegrating tablets (ODTs), multi-particulates, and modified release formulations.

Pharmaceutical and biotechnology companies approach external development and manufacturing partners for solutions for their product’s specific needs.